Physician profile
Mark A Hernandez
NPI 1881679421
$2,478.79
in general payments reported to CMS, 2019-2025
11 companies · $73.86 in 2025
The $73.86 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $1,074 · 2021: $198 · 2022: $149 · 2023: $782 · 2025: $73.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,116.99 | 2019-2025 | Grafix Pl, Stravix, Oasis |
| Ethicon INC. | $830.43 | 2022-2023 | Monarch Platform |
| Janssen Pharmaceuticals, INC | $287.82 | 2019-2021 | |
| Getinge USA Sales, LLC | $71.14 | 2020 | |
| Pfizer INC. | $51.95 | 2019-2023 | |
| Gt Metabolic Solutions INC | $46.68 | 2025 | |
| Melinta Therapeutics, LLC | $35.00 | 2021 | |
| Abbott Laboratories | $22.28 | 2019 | |
| Alkermes, INC. | $16.50 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.